CP
COV

Camelot Portfolios’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Camelot Portfolios’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,822
Closed -$902K – 189
2014
Q4 		$902K Sell
8,822
-661
-7% -$63.4K 0.52% 59
2014
Q3 		$820K Buy
9,483
+428
+5% +$37.9K 0.48% 67
2014
Q2 		$817K Buy
9,055
+630
+7% +$47.1K 0.53% 59
2014
Q1 		$621K Buy
8,425
+323
+4% +$22.5K 0.42% 71
2013
Q4 		$552K Sell
8,102
-1,126
-12% -$73.3K 0.36% 81
2013
Q3 		$562K Sell
9,228
-727
-7% -$44.4K 0.41% 72
2013
Q2 		$555K Buy
+9,955
New +$576K 0.42% 71

Camelot Portfolios's COV Position: Q1 2015 in Review

Camelot Portfolios sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 8,822 shares — an estimated $902K sold.

Camelot Portfolios first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $902K in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Camelot Portfolios reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Camelot Portfolios sold 8,822 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $902K.
  • Camelot Portfolios first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Camelot Portfolios's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $902K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Camelot Portfolios's 13F filing for Q1 2015, filed 30 Apr 2015.